MabSpace raises $40M series B

MabSpace Biosciences Co. Ltd. (Suzhou, China) raised $40 million in a series B round led by new investor Sequoia Capital China, with participation from new investor King Star Capital and existing investor Lilly Asia Ventures.

MabSpace CEO Xueming Qian told BioCentury the financing gives the company 18 months of runway and that the company has raised $60 million in total...